BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38766983)

  • 1. Safety and infectious outcomes in pediatric kidney transplant recipients after COVID-19 vaccination: A pediatric nephrology research consortium study.
    Churilla T; Crane C; Sreedharan R; Alzarka BJ; Charnaya O; Jain NG; Pizzo H; Mansuri A; Jain A; Grewal M; Fishbein JD; Kula AJ; Heald-Sargent T; Matossian D; Verghese PS
    Pediatr Transplant; 2024 Jun; 28(4):e14786. PubMed ID: 38766983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between PIRCHE-II scores and de novo allosensitization after reduction of immunosuppression during SARS-CoV-2 infection in kidney transplant recipients.
    Castrezana-Lopez K; Malchow R; Nilsson J; Kokkonen SM; Rho E; von Moos S; Mueller TF; Schachtner T
    Transpl Infect Dis; 2023 Apr; 25(2):e14052. PubMed ID: 36884207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination.
    Al Jurdi A; Gassen RB; Borges TJ; Solhjou Z; Hullekes FE; Lape IT; Efe O; Alghamdi A; Patel P; Choi JY; Mohammed MT; Bohan B; Pattanayak V; Rosales I; Cravedi P; Kotton CN; Azzi JR; Riella LV
    Front Immunol; 2022; 13():838985. PubMed ID: 35281011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
    McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
    Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-directed immunologic safety of COVID-19 vaccination in renal transplant recipients.
    Kueht M; Kirk K; Scott Lea A; Stevenson HL; Fair J; Kathleen Gamilla-Crudo A; Hussain S; Mujtaba M
    Hum Immunol; 2022; 83(8-9):607-612. PubMed ID: 35871882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and Effects of Vaccination on Sars-Cov-2 Omicron Infection in Kidney Transplant Recipients.
    Chiu HF; Tsai SF; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2023 May; 55(4):820-823. PubMed ID: 37208223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients.
    Peters LL; Raymer DS; Pal JD; Ambardekar AV
    JAMA Cardiol; 2022 Jun; 7(6):651-654. PubMed ID: 35475896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 vaccine in pediatric post-kidney transplantation.
    Ajlan AA; Aleid H; Ali T; DeVol E; Marquez KAH; Aldhaferi R; Karar EM; Mohammed AEI; Tiba M; Fajji L; Aldakhil H; Al-Awwami M; Almslam MS; Assiri A; Algoufi T; Broering DC
    Clin Transplant; 2023 Jun; 37(6):e14983. PubMed ID: 37026809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-human leukocyte antigen and anti-ABO antibodies after SARS-CoV-2 mRNA vaccination in kidney transplant recipients.
    Nishida H; Takai S; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Tsuchiya N
    Clin Transplant; 2023 May; 37(5):e14952. PubMed ID: 36846878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.
    Solomon S; Colovai A; Del Rio M; Hayde N
    Pediatr Nephrol; 2020 Feb; 35(2):261-270. PubMed ID: 31732803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.
    Bertrand D; Hamzaoui M; Lemée V; Lamulle J; Hanoy M; Laurent C; Lebourg L; Etienne I; Lemoine M; Le Roy F; Nezam D; Plantier JC; Boyer O; Guerrot D; Candon S
    J Am Soc Nephrol; 2021 Sep; 32(9):2147-2152. PubMed ID: 34112706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients.
    Haskin O; Ashkenazi-Hoffnung L; Ziv N; Borovitz Y; Dagan A; Levi S; Koren G; Hamdani G; Levi-Erez D; Landau D; Alfandary H
    Transplantation; 2021 Nov; 105(11):e226-e233. PubMed ID: 34381004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.
    Karaba AH; Morgenlander WR; Johnston TS; Hage C; Pekosz A; Durand CM; Segev DL; Robien MA; Heeger PS; Larsen CP; Blankson JN; Werbel WA; Larman HB; Tobian AAR
    J Infect Dis; 2024 May; 229(5):1366-1371. PubMed ID: 38019656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between SARS-CoV-2 Messenger RNA Vaccines and Lower Infection Rates in Kidney Transplant Recipients : A Registry-Based Report.
    Zahradka I; Petr V; Modos I; Magicova M; Dusek L; Viklicky O
    Ann Intern Med; 2022 Jul; 175(7):961-968. PubMed ID: 35500256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to third SARS-CoV-2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction.
    Kantauskaite M; Müller L; Hillebrandt J; Lamberti J; Fischer S; Kolb T; Ivens K; Koch M; Andree M; Lübke N; Schmitz M; Luedde T; Orth HM; Feldt T; Schaal H; Adams O; Schmidt C; Kittel M; Königshausen E; Rump LC; Timm J; Stegbauer J
    Clin Transplant; 2022 Nov; 36(11):e14790. PubMed ID: 35997031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the influenza vaccine on pediatric kidney transplant outcomes.
    Camerino M; Jackson S; Chinnakotla S; Verghese P
    Pediatr Transplant; 2019 Mar; 23(2):e13354. PubMed ID: 30714274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
    Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
    Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients.
    Crane C; Phebus E; Ingulli E
    Pediatr Nephrol; 2022 Feb; 37(2):449-453. PubMed ID: 34522992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.